Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma

References

• Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294:605-9; PMID:11567106; http://dx.doi.org/10.1126/science.1063916
   PubMed Web of Science ®Google Scholar
• Silva-Santos B, Serre K, Norell H. gammadelta T cells in cancer. Nat Rev Immunol 2015; 15:683-91; PMID:26449179; http://dx.doi.org/10.1038/nri3904
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 2015; 21:938-45; PMID:26193342; http://dx.doi.org/10.1038/nm.3909
   PubMed Web of Science ®Google Scholar
• Lanca T, Silva-Santos B. The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy. Oncoimmunology 2012; 1:717-25; PMID:22934263; http://dx.doi.org/10.4161/onci.20068
   PubMed Web of Science ®Google Scholar
• Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med 2011; 208:491-503; PMID:21383056; http://dx.doi.org/10.1084/jem.20100269
   PubMed Web of Science ®Google Scholar
• Cheng M, Qian L, Shen G, Bian G, Xu T, Xu W, Hu S. Microbiota modulate tumoral immune surveillance in lung through a gammadeltaT17 immune cell-dependent mechanism. Cancer Res 2014; 74:4030-41; PMID:24947042; http://dx.doi.org/10.1158/0008-5472.CAN-13-2462
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Dejima T, Yamada H, Shibata K, Nakamura R, Eto M, Nakatani T, Naito S, Yoshikai Y. IL-17 production by gammadelta T cells is important for the antitumor effect of mycobacterium bovis bacillus Calmette-Guerin treatment against bladder cancer. Eur J Immunol 2011; 41:246-51; PMID:21182095; http://dx.doi.org/10.1002/eji.201040773
   PubMed Web of Science ®Google Scholar
• Lo Presti E, Dieli F, Meraviglia S. Tumor-infiltrating gammadelta T lymphocytes: Pathogenic role, clinical significance, and differential programing in the tumor microenvironment. Front Immunol 2014; 5:607; PMID:25505472; http://dx.doi.org/10.3389/fimmu.2014.00607
   PubMed Web of Science ®Google Scholar
• Rei M, Pennington DJ, Silva-Santos B. The Emerging Protumor Role of gammadelta T lymphocytes: Implications for cancer immunotherapy. Cancer Res 2015; 75(5):798-802; PMID:25660949; http://dx.doi.org/10.1158/0008-5472.CAN-14-3228
   PubMed Web of Science ®Google Scholar
• Jianjun Y, Zhang R, Lu G, Shen Y, Peng L, Zhu C, Cui M, Wang W, Arnaboldi P, Tang M et al. T cell-derived inducible nitric oxide synthase switches off Th17 cell differentiation. J Exp Med 2013; 210:1447-62; PMID:23797094; http://dx.doi.org/10.1084/jem.20122494
   PubMed Web of Science ®Google Scholar
• Obermajer N, Wong JL, Edwards RP, Chen K, Scott M, Khader S, Kolls JK, Odunsi K, Billiar TR, Kalinski P. Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J Exp Med 2013; 210:1433-445; PMID:23797095; http://dx.doi.org/10.1084/jem.20121277
   PubMed Web of Science ®Google Scholar
• Eyles J, Puaux AL, Wang X, Toh B, Prakash C, Hong M, Tan TG, Zheng L, Ong LC, Jin Y et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010; 120:2030-9; PMID:20501944; http://dx.doi.org/10.1172/JCI42002
   PubMed Web of Science ®Google Scholar
• Kato M, Takahashi M, Akhand AA, Liu W, Dai Y, Shimizu S, Iwamoto T, Suzuki H, Nakashima I. Transgenic mouse model for skin malignant melanoma. Oncogene 1998; 17:1885-8; PMID:9778055; http://dx.doi.org/10.1038/sj.onc.1202077
   PubMed Web of Science ®Google Scholar
• Lengagne R, Le Gal FA, Garcette M, Fiette L, Ave P, Kato M, Briand JP, Massot C, Nakashima I, Renia L et al. Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells. Cancer Res 2004; 64:1496-501; PMID:14973052; http://dx.doi.org/10.1158/0008-5472.CAN-03-2828
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
   PubMed Web of Science ®Google Scholar
• Toh B, Wang X, Keeble J, Sim WJ, Khoo K, Wong WC, Kato M, Prevost-Blondel A, Thiery JP, Abastado JP. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 2011; 9:e1001162; PMID:21980263; http://dx.doi.org/10.1371/journal.pbio.1001162
   PubMedGoogle Scholar
• Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJ, Ciampricotti M, Hawinkels LJ, Jonkers J et al. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015; 522:345-8; PMID:25822788; http://dx.doi.org/10.1038/nature14282
   PubMed Web of Science ®Google Scholar
• Ma S, Cheng Q, Cai Y, Gong H, Wu Y, Yu X, Shi L, Wu D, Dong C, Liu H. IL-17A produced by gammadelta T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res 2014; 74:1969-82; PMID:24525743; http://dx.doi.org/10.1158/0008-5472.CAN-13-2534
   PubMed Web of Science ®Google Scholar
• Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, Wang Z, Wang C, Zhang Z, Xia W et al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014; 40:785-800; PMID:24816404; http://dx.doi.org/10.1016/j.immuni.2014.03.013
   PubMed Web of Science ®Google Scholar
• Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ et al. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol 2009; 10:427-36; PMID:19270712; http://dx.doi.org/10.1038/ni.1717
   PubMed Web of Science ®Google Scholar
• Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, Grimm EA. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 2000; 6:4768-75; PMID:11156233
   PubMed Web of Science ®Google Scholar
• Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. J Pathol 2001; 194:194-200; PMID:11400148; http://dx.doi.org/10.1002/1096-9896(200106)194:2%3c194::AID-PATH851%3e3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Johansson CC, Mougiakakos D, Trocme E, All-Ericsson C, Economou MA, Larsson O, Seregard S, Kiessling R. Expression and prognostic significance of iNOS in uveal melanoma. Int J Cancer 2010; 126:2682-9; PMID:19847812; http://dx.doi.org/10.1002/ijc.24984
   PubMed Web of Science ®Google Scholar
• Dabbeche-Bouricha E, Araujo LM, Kato M, Prevost-Blondel A, Garchon H-J. Rapid dissemination of RET-transgene driven melanoma in the presence of non-obese diabetic alleles: critical roles of Dectin-1 and Nitric-Oxide Synthase type 2. Oncoimmunology. 2015 Oct 29; 5(5):e1100793; PMID:27467912; http://dx.doi.org/10.1080/2162402X.2015.1100793
   Google Scholar
• Wakita D, Sumida K, Iwakura Y, Nishikawa H, Ohkuri T, Chamoto K, Kitamura H, Nishimura T. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Eur J Immunol 2010; 40:1927-37; PMID:20397212; http://dx.doi.org/10.1002/eji.200940157
   PubMed Web of Science ®Google Scholar
• Mattarollo SR, Loi S, Duret H, Ma Y, Zitvogel L, Smyth MJ. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Res 2011; 71:4809-20; PMID:21646474; http://dx.doi.org/10.1158/0008-5472.CAN-11-0753
   PubMed Web of Science ®Google Scholar
• Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, Craft J, Yin Z. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 2003; 198:433-42; PMID:12900519; http://dx.doi.org/10.1084/jem.20030584
   PubMed Web of Science ®Google Scholar
• He W, Hao J, Dong S, Gao Y, Tao J, Chi H, Flavell R, O'Brien RL, Born WK, Craft J et al. Naturally activated V gamma 4 gamma delta T cells play a protective role in tumor immunity through expression of eomesodermin. J Immunol 2010; 185:126-33; PMID:20525896; http://dx.doi.org/10.4049/jimmunol.0903767
   PubMed Web of Science ®Google Scholar
• Lanca T, Costa MF, Goncalves-Sousa N, Rei M, Grosso AR, Penido C, Silva-Santos B. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic gammadelta T lymphocytes to tumor beds. J Immunol 2013; 190:6673-80; PMID:23686489; http://dx.doi.org/10.4049/jimmunol.1300434
   PubMed Web of Science ®Google Scholar
• Carmi Y, Rinott G, Dotan S, Elkabets M, Rider P, Voronov E, Apte RN. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis. J Immunol 2011; 186:3462-71; PMID:21300825; http://dx.doi.org/10.4049/jimmunol.1002901
   PubMed Web of Science ®Google Scholar
• Hao J, Dong S, Xia S, He W, Jia H, Zhang S, Wei J, O'Brien RL, Born WK, Wu Z et al. Regulatory role of Vgamma1 gammadelta T cells in tumor immunity through IL-4 production. J Immunol 2011; 187:4979-86; PMID:21987661; http://dx.doi.org/10.4049/jimmunol.1101389
   PubMed Web of Science ®Google Scholar
• Paget C, Chow MT, Duret H, Mattarollo SR, Smyth MJ. Role of gammadelta T cells in alpha-galactosylceramide-mediated immunity. J Immunol 2012; 188:3928-39; PMID:22412194; http://dx.doi.org/10.4049/jimmunol.1103582
   PubMed Web of Science ®Google Scholar
• Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001; 2:907-16; PMID:11577346; http://dx.doi.org/10.1038/ni1001-907
   PubMed Web of Science ®Google Scholar
• Caccamo N, La Mendola C, Orlando V, Meraviglia S, Todaro M, Stassi G, Sireci G, Fournie JJ, Dieli F. Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells. Blood 2011; 118:129-38; PMID:21505189; http://dx.doi.org/10.1182/blood-2011-01-331298
   PubMed Web of Science ®Google Scholar
• Bogdan C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol 2015; 36(3):161-78; PMID:25687683; http://dx.doi.org/10.1016/j.it.2015.01.003
   PubMed Web of Science ®Google Scholar
• Saini AS, Shenoy GN, Rath S, Bal V, George A. Inducible nitric oxide synthase is a major intermediate in signaling pathways for the survival of plasma cells. Nat Immunol 2014; 15:275-82; PMID:24441790; http://dx.doi.org/10.1038/ni.2806
   PubMed Web of Science ®Google Scholar
• Lengagne R, Pommier A, Caron J, Douguet L, Garcette M, Kato M, Avril MF, Abastado JP, Bercovici N, Lucas B et al. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma. PLoS One 2011; 6:e20235; PMID:21633700; http://dx.doi.org/10.1371/journal.pone.0020235
   PubMed Web of Science ®Google Scholar